ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002

Study Seeks Newly Diagnosed Prostate Cancer Patients

March 26, 2010

Clinton Names Broadnax HHS Deputy, Others to Sub-Cabinet Posts

March 5, 1993

NCI Clinical Research Too Similar To Work By Extramural Community, Report Finds

July 21, 1995

In Brief: Congresswomen Receive FASEB Awards for Public Service for Support of NIH

May 2, 1997

Study Finds Relationship Between Meat Intake, Cancer

August 27, 2010